Current liabilities increased 13.3%
Current liabilities changed +13.3% from the comparable as-filed period. The change ranks at the 75th percentile of 4 prior comparable changes.
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Current liabilities changed +13.3% from the comparable as-filed period. The change ranks at the 75th percentile of 4 prior comparable changes.
Shares outstanding changed -8.1% from the comparable as-filed period. The change ranks at the 75th percentile of 8 prior comparable changes.
Operating cash flow / net income changed -39.2% from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
Revenue changed +10.6% from the comparable as-filed period.
Working capital / assets changed -433 basis points from the comparable as-filed period.
Operating cash-flow margin changed -515 basis points from the comparable as-filed period.
Free-cash-flow margin changed -506 basis points from the comparable as-filed period.
Receivables / revenue changed +239 basis points from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
Net income changed +11.5% from the comparable as-filed period.
Total assets changed +5.8% from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
Current ratio changed -18.3% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
Capex / revenue changed -9 basis points from the comparable as-filed period.
Current assets changed -7.5% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes.
Inventory / revenue changed -20 basis points from the comparable as-filed period.
Cost of revenue changed +7.0% from the comparable as-filed period.
Inventory changed -5.9% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes.
Capital expenditure changed +7.0% from the comparable as-filed period.
Selling, general & administrative changed +5.4% from the comparable as-filed period.
Working capital changed -112.6% from the comparable as-filed period. The change ranks at the 75th percentile of 4 prior comparable changes. Relative percentage is de-emphasized because the comparison has a sign change.
Operating cash flow / net income changed -52.6% from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
Revenue changed +8.8% from the comparable as-filed period.
Free-cash-flow margin changed -955 basis points from the comparable as-filed period.
Working capital / assets changed -1505 basis points from the comparable as-filed period.
Operating cash-flow margin changed -980 basis points from the comparable as-filed period.
Total assets changed -8.0% from the comparable as-filed period.
Receivables / revenue changed -186 basis points from the comparable as-filed period.
Inventory changed -16.6% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
Capex / revenue changed -25 basis points from the comparable as-filed period.
Inventory / revenue changed -35 basis points from the comparable as-filed period.
Selling, general & administrative changed +14.8% from the comparable as-filed period.
Cost of revenue changed +4.1% from the comparable as-filed period.
Trade receivables changed +2.0% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes.
Capital expenditure changed -1.8% from the comparable as-filed period.
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.